July 18, 2023 Fact-sheet: Case 1 – Open Contracts Educational Material, Transparency Note: This statement was first published in February 2022.
Educational Material, Fair Access, Gilead License FAQ: Gilead’s LENACAPAVIR (LEN-LA) license and implications for access
